These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6443377)

  • 1. Naltrexone in addicted physicians and business executives.
    Washton AM; Gold MS; Pottash AC
    NIDA Res Monogr; 1984; 55():185-90. PubMed ID: 6443377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of naltrexone in addicted physicians and business executives.
    Washton AM; Gold MS; Pottash AC
    Adv Alcohol Subst Abuse; 1984; 4(2):89-96. PubMed ID: 6524509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the National Institute on Drug Abuse in the development of naltrexone.
    Ginzburg HM; Glass WJ
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):4-6. PubMed ID: 6088469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone in addicted business executives and physicians.
    Washton AM; Pottash AC; Gold MS
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):39-41. PubMed ID: 6088468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
    Roozen HG; Deden AL; Kerkhof AJ; Vorsteveld JP; van den Brink W
    Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2377-80. PubMed ID: 9554156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
    Gold MS; Dackis CA; Washton AM
    Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
    Gold MS
    Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clonidine-naltrexone: a new technic for the detoxification of opiate addicts].
    Oliveros SC; Caballero L; Iruela LM
    Med Clin (Barc); 1990 Nov; 95(16):627-9. PubMed ID: 2097456
    [No Abstract]   [Full Text] [Related]  

  • 10. Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.
    Rawson RA; Washton AM; Resnick RB; Tennant FS
    Adv Alcohol Subst Abuse; 1984; 3(3):41-9. PubMed ID: 6093484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with naltrexone in suburban opioid addicts.
    Tennant FS; Rawson RA; Cohen AJ; Mann A
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Naltrexone and prevention of opiate dependence relapse. An Italian experience].
    Cibin M; Gentile N; Ferri M; Gallimberti L
    Minerva Psichiatr; 1989; 30(2):93-8. PubMed ID: 2779401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of naltrexone maintenance following ultra rapid opiate detoxification versus intensive inpatient detoxification.
    Rabinowitz J; Cohen H; Atias S
    Am J Addict; 2002; 11(1):52-6. PubMed ID: 11876583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of naltrexone in the treatment of opiate addicts. Efficacy and indications for type categories].
    Faro G; Jarre P; Martucci M; Sargiotto A; Eandi M
    Clin Ter; 1991 Nov 15-30; 139(3-4):93-9. PubMed ID: 1837256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol].
    Fontaine E; Godfroid IO; Guillaume R
    Encephale; 2001; 27(2):187-93. PubMed ID: 11407272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification.
    Davison JW; Sweeney ML; Bush KR; Davis Correale TM; Calsyn DA; Reoux JP; Sloan KL; Kivlahan DR
    J Addict Dis; 2006; 25(4):27-35. PubMed ID: 17088223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR.
    Azatian A; Papiasvilli A; Joseph H
    J Addict Dis; 1994; 13(1):35-52. PubMed ID: 8018739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone induction: psychologic and pharmacologic strategies.
    Kleber HD; Kosten TR
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):29-38. PubMed ID: 6469934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.